PSMA-617 Solid-Phase Synthesis for High-Purity Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for cost-effective synthesis methods that can deliver high-purity quantities of urea-based PSMA ligands, particularly PSMA-617, which are crucial for the treatment of prostate cancer due to their potential in Radio Ligand Therapy (RLT) and high unmet medical need in aggressive castration-resistant variants.
Innovation Solution
A method for synthesizing PSMA-617 using solid phase synthesis, involving a series of steps with resin-based compounds and specific protecting groups, linkers, and reagents, which allows for efficient and cost-effective production with yields greater than or equal to 20%.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional synthesis methods are used for PSMA-617, then the synthesis process can be performed, but the production cost is high and the purity is insufficient
Solution Approach 1:
The synthesis process is divided into multiple discrete steps (a-h) with specific protecting groups and deprotection steps, allowing for controlled purification at each stage. The solid-phase synthesis approach segments the molecular assembly into manageable coupling reactions, improving overall purity while maintaining cost-effectiveness through efficient resource utilization.
Solution Approach 2:
Protecting groups (PG, PG1, PG2, PG3, PG4, PG5, PG6, PG7) are strategically placed on functional groups before synthesis begins. These preliminary protective measures prevent unwanted side reactions during the synthesis process, ensuring high purity of the final product without requiring expensive post-synthesis purification steps.
2Productivity
If conventional synthesis methods are used for PSMA-617, then the synthesis can proceed, but the production efficiency is low
Solution Approach 1:
The solid-phase synthesis methodology enables continuous synthesis operations where each step (a-h) flows into the next without interruption. The resin-based approach allows for continuous addition of reagents and sequential transformations, maximizing productivity while minimizing idle time between synthesis steps.
Solution Approach 2:
The solid-phase resin system performs self-service functions by automatically facilitating coupling reactions and protecting group manipulations. The resin matrix itself provides the structural framework that guides the synthesis process, reducing the need for external intervention and accelerating overall production efficiency.
3Manufacturing precision
If solid phase synthesis with resin-based compounds is used, then the synthesis efficiency and purity are improved, but the process complexity increases
Solution Approach 1:
The solid-phase resin system serves multiple functions simultaneously: it provides the structural scaffold for molecular assembly, acts as a filtering medium for purification, and facilitates protecting group manipulations. This multi-functionality consolidates what would otherwise require separate equipment and procedures, managing process complexity while maintaining high purity.
Solution Approach 2:
The resin-based compound acts as an intermediary carrier that temporarily holds the growing molecule during synthesis. This intermediary approach simplifies the overall process by providing a stable platform for sequential reactions, making the complex multi-step synthesis more manageable and controllable.
Data Source
Figure 1
AI summary
The present disclosure relates to the synthesis of prostate specific membrane antigen (PSMA) ligands that are useful in the treatment of diseases like cancer. In particular, the disclosure relates to a method for synthesizing PSMA ligands having a glutamate-urea-lysine (GUL) moiety and a chelating agent that can comprise a radiometal.